Ocular myasthenia gravis patients following the administration of tacrolimus and steroids

Efficacy and safety of low-dose tacrolimus (3–5 mg/day) in steroid-resistant adult myasthenia gravis (MG) patients have been demonstrated in double-blind studies [1,2]. Tacrolimus promotes muscle strength recovery with lower doses of steroids in adults [1]. However, reports on tacrolimus use in children are scarce [3,4]. Although childhood-onset MG has better steroid reactivity and improved prognosis compared with adult-onset cases [5], some refractory pediatric MG cases are nonresponsive to steroids [6,7].

Source link

Related posts

Could beef jerky contribute to manic episodes?


New data indicates rise in opioid use for migraine treatment


Comment: MRI provides insights into remote degeneration after cervical cord injury


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy